Amphix Bio
Amphix Bio is a biotechnology company developing a new class of peptide therapeutics for neurological injuries, neurodegenerative diseases, and musculoskeletal disorders. The company’s Supramolecular Therapeutic Peptide (STP) platform assembles nanostructures that activate cell receptors and combines peptide modifications with a proprietary sequence library to optimize therapeutic properties.
Leadership & Board
- Current Number of Employees
- 10
- Current LinkedIn Followers
- 711
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $13M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $13M
- Latest Funding Round
- Seed Round
- Post-Money Valuation
- ―
Employee Trend
Amphix Bio had 10 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Amphix Bio had 711 followers as of October 12, 2026. The number of followers increased by 6 (0.85%) week-over-week.
711Latest Followers Count
6(0.85%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 18, 2025 | Seed Round | $12.50M | ― |
Similar Companies
A snapshot of private companies similar to Amphix Bio, helping you discover and navigate related company profiles.
Related News and Analysis
